Table 3.
Independent variables | ICU mortalitya | |||
---|---|---|---|---|
Univariate analysis | Multivariable analysisb | |||
HR (95 % CI) | P-value | HR (95 % CI) | P-value | |
Baseline variables | ||||
Male | 1.52 (1.01-2.22) | 0.042 | 1.41 (0.95-2.08) | 0.096 |
APACHE II scorec | 1.20 (1.07-1.35) | 0.002 | 1.22 (1.07-1.37) | 0.002 |
Chronic respiratory disease | 1.47 (0.97-2.23) | 0.071 | 1.27 (0.81-1.97) | 0.30 |
Chronic heart failure | 2.48 (1.33-4.64) | 0.004 | 2.58 (1.34-4.97) | 0.004 |
History of venous thromboembolism | 0.28 (0.068-1.16) | 0.078 | 0.46 (0.11-1.91) | 0.29 |
Immunocompromise | 1.45 (0.91-2.33) | 0.11 | 1.54 (0.94-2.52) | 0.084 |
BMIc | 0.97 (0.85-1.10) | 0.61 | -d | -d |
History of malignancy | 1.29 (0.57-2.94) | 0.54 | -d | -d |
Medical admission | 1.24 (0.31-5.04) | 0.76 | -d | -d |
End-stage renal disease | 1.49 (0.50-4.40) | 0.47 | -d | -d |
Chronic hepatic failure | 1.21 (0.17-8.67) | 0.85 | -d | -d |
Daily intervention variables | ||||
Inotropes/vasopressors | 1.35 (0.92-1.98) | 0.12 | 1.29 (0.88-1.92) | 0.19 |
Dialysis | 2.06 (1.04-4.09) | 0.039 | 1.64 (0.77-3.52) | 0.20 |
Red blood cell transfusion | 1.60 (0.83-3.09) | 0.16 | 1.30 (0.63-2.70) | 0.48 |
Central venous catheterization | 1.75 (0.93-3.27) | 0.081 | 1.63 (0.92-2.87) | 0.090 |
Erythropoietin-stimulating agents | 2.66 (0.65-10.85) | 0.17 | 1.15 (0.23-5.79) | 0.86 |
Mechanical ventilation | 1.05 (0.46-2.40) | 0.91 | -d | -d |
Acetylsalicylic acid or clopidogrel | 1.22 (0.82-1.81) | 0.32 | -d | -d |
Statins | 0.93 (0.56-1.55) | 0.78 | -d | -d |
Stress ulcer prophylaxis | 1.33 (0.64-2.74) | 0.44 | -d | -d |
Activated protein C | 0.86 (0.21-3.50) | 0.84 | -d | -d |
HR hazard ratio, CI confidence interval, BMI body mass index, APACHE Acute Physiology and Chronic Health Evaluation
aThere were 108 deaths for 90-day ICU mortality
bNo multicollinearity detected
cResults for 5-point increase
dNot included in the multivariable analysis